These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Increased prevalence of DRw3 in the CREST syndrome. Germain BF, Espinoza LR, Bergen LL, Vagesh M, Vasey FB. Arthritis Rheum; 1981 Jun; 24(6):857-9. PubMed ID: 6941787 [No Abstract] [Full Text] [Related]
7. Anticentromere and anticentriole antibodies in the scleroderma spectrum. Tuffanelli DL, McKeon F, Kleinsmith DM, Burnham TK, Kirschner M. Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899 [Abstract] [Full Text] [Related]
8. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Fritzler MJ, Kinsella TD. Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511 [Abstract] [Full Text] [Related]
9. Characterisation of centromere (kinetochore) antigen reactive with sera of patients with a scleroderma variant (CREST syndrome). Nishikai M, Okano Y, Yamashita H, Watanabe M. Ann Rheum Dis; 1984 Dec; 43(6):819-24. PubMed ID: 6524984 [Abstract] [Full Text] [Related]
10. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma]. Rouquette-Gally AM, Stern MH, Prost AC, Abuaf N, Homberg JC, Combrisson A. Presse Med; 1984 Dec; 14(28):1497-500. PubMed ID: 2931679 [Abstract] [Full Text] [Related]
15. Calcinosis circumscripta. A case report. Wong AC, Asai M, Masuda K, Wada E, Matsunaga T, Akahoshi Y. J Bone Joint Surg Am; 1986 Feb; 68(2):297-9. PubMed ID: 2935536 [No Abstract] [Full Text] [Related]